Lansoprazole enteric coated tablet and preparation method thereof
A technology for lansoprazole intestine and lansoprazole, which is applied in the field of pharmaceutical preparations, can solve problems such as the inability to better improve the dissolution rate of lansoprazole tablets, and achieves controllable product quality, guaranteed stability, and high efficiency. The effect of practical value
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0042] Drugs and excipients (make 100 tablets):
[0043] (1) chip
[0044]Lansoprazole 1.50g
[0045] Heavy Magnesium Carbonate 1.50g
[0046] Microcrystalline Cellulose 1.00g
[0047] Lactose 2.00g
[0048] Croscarmellose Sodium 2.00g
[0049] Sodium carboxymethyl starch 0.50g
[0050] Poloxamer 0.75g
[0051] 5% PVP-K30 (absolute ethanol) 1.40ml
[0052] Magnesium Stearate Appropriate amount
[0053] (2) Isolation coating layer
[0054] Talc powder 3.00g
[0055] Titanium dioxide 9.00g
[0056] 5% PVP (absolute ethanol) 100.00ml
[0057] (3) Enteric coating layer
[0058] Eudraki 60.00g
[0059] PEG60006.00g
[0060] Talc powder 15.00g
[0061] Absolute ethanol 919.00g
[0062] Preparation
[0063] (1) Preparation of tablet core
[0064] Main drug micronization (95% particle diameter is not more than 5 μm) and lactose, microcrystalline cellulose, heavy magnesium carbonate, croscarmellose sodium cross 100 mesh sieves and mix evenly, and poloxamer is dissolve...
Embodiment 3
[0113] Drugs and excipients (make 100 tablets):
[0114] (1) chip
[0115] Lansoprazole 1.5g
[0116] Heavy Magnesium Carbonate 1.5g
[0117] Microcrystalline Cellulose 1.0g
[0118] Lactose 2.5g
[0119] Croscarmellose Sodium 1.5g
[0120] Sodium carboxymethyl starch 0.6g
[0121] Poloxamer 0.75g
[0122] 5% PVP-K30 (absolute ethanol) 1.4ml
[0123] Magnesium Stearate Appropriate amount
[0124] (2) Isolation coating layer
[0125] Talc powder 3.00g
[0126] Titanium dioxide 9.00g
[0127] 5% PVP (absolute ethanol) 100.00ml
[0128] (3) Enteric coating layer
[0129] Eudraki 60.0g
[0130] PEG60006.0g
[0131] Talc powder 15.0g
[0132] Absolute ethanol 919.0g
[0133] Preparation
[0134] (1) Preparation of tablet core
[0135] Main drug micronization (95% particle size is not more than 5 μm) and lactose, microcrystalline cellulose, heavy magnesium carbonate, croscarmellose sodium cross 100 mesh sieve and mix evenly, the poloxamer of prescription amount Diss...
PUM
| Property | Measurement | Unit |
|---|---|---|
| particle diameter | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
Login to View More 